AbbVie Inc (ABBV)

Return on assets (ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands 4,863,000 6,514,000 8,685,000 7,585,000 11,836,000 13,407,000 12,637,000 12,479,000 11,542,000 7,534,000 6,663,000 5,159,000 4,616,000 7,381,000 6,957,000 8,436,000 7,882,000 3,255,000 4,118,000 5,360,000
Total assets US$ in thousands 134,711,000 136,221,000 135,367,000 134,544,000 138,805,000 141,325,000 143,186,000 143,211,000 146,529,000 148,858,000 147,972,000 150,501,000 150,565,000 149,621,000 149,530,000 91,199,000 89,115,000 59,441,000 57,142,000 56,769,000
ROA 3.61% 4.78% 6.42% 5.64% 8.53% 9.49% 8.83% 8.71% 7.88% 5.06% 4.50% 3.43% 3.07% 4.93% 4.65% 9.25% 8.84% 5.48% 7.21% 9.44%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $4,863,000K ÷ $134,711,000K
= 3.61%

Analyzing Abbvie Inc's return on assets (ROA) over the past eight quarters reveals fluctuations in the company's efficiency in generating profits from its assets. ROA peaked at 9.44% in Q3 2022 and has experienced a gradual decline since then. In the most recent quarter, Q4 2023, ROA stands at 3.58%, marking a significant decrease from the previous quarter's 4.76%. Despite this decline, the company's ROA levels remain above 3% consistently, indicating that Abbvie Inc continues to effectively utilize its assets to generate profits, albeit with some volatility in performance. Further analysis is recommended to understand the underlying factors impacting the company's ROA trend and to assess its long-term sustainability.


Peer comparison

Dec 31, 2023


See also:

AbbVie Inc Return on Assets (ROA) (Quarterly Data)